Cargando…

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion

OBJECTIVE: Understanding the price components of the mifepristone/misoprostol (combi-pack) for medical abortion to improve access is critical for identifying strategies to reduce product costs for quality-assured formulations and expanding its availability and use. METHODS: We constructed a cost of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinery, Lester, Allaouidine, Chadia, Tomazzini, Alessandra, Larson, Melanie, Gülmezoglu, A. Metin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640653/ https://www.ncbi.nlm.nih.gov/pubmed/33148282 http://dx.doi.org/10.1186/s12978-020-01012-8

Ejemplares similares

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats
por: Sedita, Jeff, et al.
Publicado: (2018)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss
por: Hamel, Charlotte C., et al.
Publicado: (2022)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Regulatory standards and processes for over-the-counter availability of hormonal contraception and drugs for medical abortion in five countries in the Eastern Mediterranean Region
por: Ammerdorffer, Anne, et al.
Publicado: (2021)

Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study
por: Schellekens, Julia EAP, et al.
Publicado: (2022)

Factors Influencing the Duration of Termination of Pregnancy for Fetal Anomaly with Mifepristone in Combination with Misoprostol
por: Reischer, Theresa, et al.
Publicado: (2023)

Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study
por: Panda, Subrat, et al.
Publicado: (2013)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
por: Abubeker, Ferid A., et al.
Publicado: (2020)

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
por: Chu, Justin J, et al.
Publicado: (2020)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Medication Abortion Safety and Effectiveness With Misoprostol Alone
por: Jayaweera, Ruvani, et al.
Publicado: (2023)

Cannabis Users' Recommended Warnings for Packages of Legally Sold Cannabis: An Australia-Centered Study
por: Malouff, John M., et al.
Publicado: (2016)

Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice
por: KIM, SEONG-KWAN, et al.
Publicado: (2015)

Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series
por: Esposito, Leah, et al.
Publicado: (2023)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions
por: Szpot, Paweł, et al.
Publicado: (2022)

Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination
por: von Hertzen, Helena, et al.
Publicado: (2008)

Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days’ gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
por: Dragoman, Monica V., et al.
Publicado: (2016)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
por: Hamel, Charlotte, et al.
Publicado: (2021)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

In the name of public health: misoprostol and the new criminalization of abortion in Brazil
por: Assis, Mariana Prandini, et al.
Publicado: (2021)

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial)
por: van den Berg, Joyce, et al.
Publicado: (2019)

Bacterial contamination of packaged smokeless tobacco sold in India
por: Mehra, Rashmi, et al.
Publicado: (2020)

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
por: Gupta, Anjali, et al.
Publicado: (2023)

Assessing the content of a package of SGT-151 sold online
por: Luzio, Ana, et al.
Publicado: (2021)

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings
por: Lang, Danielle L., et al.
Publicado: (2015)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcmavqabvs12mtgcuqab2no4sa